Inventor

WU HERREN

US53 patents

⚠️ This page may combine multiple inventors who share the name “WU HERREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WU HERREN

MEDIMMUNE LLC

High potency recombinant antibodies and method for producing them

Molecules with extended half-lives, compositions and uses thereof

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Ultra high affinity neutralizing antibodies

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Cell display of antibody libraries

Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

High affinity antibodies against HMGB1 and methods of use thereof

Modulation of antibody effector function by hinge domain engineering

Humanized anti-CD19 antibodies

High affinity antibodies against HMGB1 and methods of use thereof

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Cell display of antibody libraries

MEDIMMUNE INC

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Anti-RSV antibodies

Ultra high affinity neutralizing antibodies

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment

Recombinant IL-9 antibodies

WU HERREN

Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells

Protein scaffolds

Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells

High affinity antibodies against HMGB1 and methods of use thereof

High affinity antibodies against HMGB1 and methods of use thereof

AN LING-LING

Humanized anti-factor D antibodies

Nucleic acids encoding anti-factor D antibodies

Methods of treating with anti-factor D antibodies

APPLIED MOLECULAR EVOLUTION

Methods of inhibiting αvβ3-mediated binding with αvβ3-specific antibodies

Methods of optimizing antibody variable region binding affinity

αvβ3-specific antibodies

IXSYS INC

Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same

Methods of optimizing antibody variable region binding affinity

GENENTECH INC

Humanized anti-factor D antibodies and uses thereof

Methods of detecting factor D with anti-factor D antibodies

SINGH SANJAYA

High affinity, anti-human IgE antibodies

High affinity, anti-human IgE antibodies

GAO CHANGSHOU

Mutant antibody Fc domains and fusion proteins thereof

TANOX INC

High affinity anti-human IgE antibodies

(unassigned)

Antibodies against human CD40

DALL ACQUA WILLIAM

Modulation of antibody effector function by hinge domain engineering

ALLAN CHRISTIAN

Integrated approach for generating multidomain protein therapeutics

YOUNG JAMES F

High potency recombinant antibodies and method for producing them

DAMSCHRODER MELISSA

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

BEDIAN VAHE

Stabilized angiopoietin-2 antibodies and uses thereof

ASTRAZENECA AB

Anti-IFNAR1 antibodies with reduced Fc ligand affinity

MEDIMMUNE LTD

Stabilized angiopoietin-2 antibodies and uses thereof

REED JENNIFER LYNNE

Recombinant IL-9 antibodies and uses thereof